Peter Haug

Peter Haug has a diverse work experience spanning multiple industries and positions. Peter is currently the Founding Angel and Co-Founder of Noscendo GmbH, where they are involved in developing bioinformatic solutions for identifying and assessing pathogens in infections. Previously, they held the role of Founding Angel and Head of Business Development and Licensing at oncgnostics GmbH. Peter also has experience as a Founding Angel and CEO of AViSpectro/AViPharm and Greasoline, as well as serving as a Member of the Management Board at Corden Pharma. Peter Haug has also worked as an Investment Manager at International Chemical Investors and as a Project Manager at 3con Management Consultants. Earlier in their career, they were a Senior Consultant at OC&C Strategy Consultants. Additionally, they have served as the Chairman of the Board at Klara Haug Umweltstiftung and as a Founding Angel and Member of the Advisory Board at 300Microns.

Peter Haug has attended the University of Stuttgart and CPE Lyon, but no specific details about their degree or field of study are provided.